Sai Life Sciences receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It provides medicinal chemistry, pharmacokinetics, manufacturing, and contract development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is based in Hyderabad, India.
Metrics to compare | SAIE | Peers Peers - average of corresponding metrics from companies closely matching SAIE: WINDLAS, LAURUSLABS, LLY, SYNGENE, DIVISLAB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSAIEPeersSector |
|---|---|---|---|---|
P/E Ratio | 59.6x | 30.6x | −0.6x | |
PEG Ratio | 0.58 | 0.29 | 0.00 | |
Price/Book | 7.5x | 4.3x | 2.6x | |
Price / LTM Sales | 8.3x | 4.7x | 3.4x | |
Upside (Analyst Target) | 40.9% | 15.6% | 42.0% | |
Fair Value Upside | Unlock | 16.7% | 5.8% | Unlock |